U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
165181165181AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/AttemptsCompletedHas ResultsAutologous Stem Cell TransplantationDrug: G-CSF plus plerixaforhttps://ClinicalTrials.gov/show/NCT00396331
165182165182A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous CathetersCompletedHas ResultsDysfunctional Central Venous Access CathetersDrug: tenecteplasehttps://ClinicalTrials.gov/show/NCT00396318
165183165183Th1 Response to Influenza: Aging and Vaccine EfficacyTerminatedNo Results AvailableInfluenzaDrug: Placebo|Biological: Trivalent Inactivated Influenzahttps://ClinicalTrials.gov/show/NCT00396305
165184165184Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum AnemiaCompletedHas ResultsAnemiaDrug: Oral iron tablets|Drug: VIT-45https://ClinicalTrials.gov/show/NCT00396292
165185165185Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of BoneCompletedHas ResultsGCT|Giant Cell Tumor of BoneBiological: Denosumab|Dietary Supplement: Calcium/Vitamin Dhttps://ClinicalTrials.gov/show/NCT00396279
165186165186AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSFCompletedHas ResultsMultiple Myeloma|Lymphoma, Non-HodgkinDrug: G-CSF Plus Plerixaforhttps://ClinicalTrials.gov/show/NCT00396266
165187165187A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) CathetersCompletedHas ResultsDysfunctional Hemodialysis CathetersDrug: Tenecteplasehttps://ClinicalTrials.gov/show/NCT00396253
165188165188ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL GoalsWithdrawnNo Results AvailablePrimary HypercholesterolaemiaDrug: Rosuvastatin|Procedure: Initiatives to improve compliancehttps://ClinicalTrials.gov/show/NCT00396240
165189165189Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as Add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin AloneCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptin|Drug: thiazolidinedione (TZD)https://ClinicalTrials.gov/show/NCT00396227
165190165190Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsTerminatedNo Results AvailableSchizophreniaDrug: Bifeprunox|Drug: Quetiapine|Drug: Bifeprunoxhttps://ClinicalTrials.gov/show/NCT00396214
165191165191AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's DiseaseCompletedHas ResultsHodgkin's DiseaseDrug: G-CSF Plus Plerixaforhttps://ClinicalTrials.gov/show/NCT00396201
165192165192Screening Aid to Identify Corneas That May Have Pathologies or Other ConditionsCompletedNo Results AvailableCorneal Diseaseshttps://ClinicalTrials.gov/show/NCT00396188
165193165193Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)CompletedNo Results AvailableAndrogenetic AlopeciaDrug: MK0906, finasteride / Duration of Treatment : 48 Weeks|Drug: Comparator : placebo (unspecified) / Duration of Treatment : 48 Weekshttps://ClinicalTrials.gov/show/NCT00396175
165194165194Use of Probiotics as Adjunctive Treatment for Chronic RhinosinusitisCompletedNo Results AvailableChronic RhinosinusitisDrug: probiotic containing L.rhamnosus R0011 strainhttps://ClinicalTrials.gov/show/NCT00396162
165195165195Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1CompletedNo Results AvailableBirch Pollen-Related Rhinoconjunctivitis|Rhinitis, Allergic, SeasonalBiological: Placebo|Biological: rBet v 1https://ClinicalTrials.gov/show/NCT00396149
165196165196COSMO Post Approval Registry: Corox OTW Steroid LV Lead MonitoringCompletedHas ResultsCongestive Heart FailureDevice: Corox OTW Steroid Left Ventricular Leadhttps://ClinicalTrials.gov/show/NCT00396136
165197165197Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC StudyActive, not recruitingNo Results AvailableChronic Kidney Disease|Anemiahttps://ClinicalTrials.gov/show/NCT00396123
165198165198Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)CompletedNo Results AvailableHypercholesterolemia|Coronary Heart Diseasehttps://ClinicalTrials.gov/show/NCT00396110
165199165199Individualized, Target-Driven Treatment Of Children With Idiopathic Short StatureCompletedHas ResultsIdiopathic Short StatureDrug: Genotropin|Drug: Genotropinhttps://ClinicalTrials.gov/show/NCT00396097
165200165200Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedHas ResultsTB Multi-drug ResistantDrug: Gatifloxacin|Drug: Levofloxacin|Drug: Moxifloxacin|Drug: Isoniazid|Drug: Linezolidhttps://ClinicalTrials.gov/show/NCT00396084
165201165201Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With MetforminCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00396071
165202165202The Effect of Methylphenidate on Motor Learning in Stroke PatientsTerminatedNo Results AvailableCerebrovascular AccidentDrug: Methylphenidatehttps://ClinicalTrials.gov/show/NCT00396058
165203165203Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Revlimid (CC-5013)https://ClinicalTrials.gov/show/NCT00396045
165204165204A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis CathetersCompletedHas ResultsDysfunctional Hemodialysis CathetersDrug: placebo|Drug: tenecteplasehttps://ClinicalTrials.gov/show/NCT00396032
165205165205Study of PEG-Intron for Plexiform NeurofibromasRecruitingNo Results AvailablePlexiform NeurofibromaDrug: PEG-Intronhttps://ClinicalTrials.gov/show/NCT00396019
165206165206Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)CompletedHas ResultsAlpha 1-Antitrypsin DeficiencyBiological: Alpha1-Proteinase Inhibitorhttps://ClinicalTrials.gov/show/NCT00396006
165207165207Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine BleedingCompletedHas ResultsAnemiaDrug: Ferric Carboxymaltose (FCM)|Drug: Ferrous Sulfate tabletshttps://ClinicalTrials.gov/show/NCT00395993
165208165208Muscle Pressure in the Flank PositionCompletedNo Results AvailableTissue BreakdownDevice: surgical table pressure mathttps://ClinicalTrials.gov/show/NCT00395980
165209165209AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF AloneTerminatedHas ResultsMultiple Myeloma|Lymphoma, Non-Hodgkin'sDrug: G-CSF plus plerixaforhttps://ClinicalTrials.gov/show/NCT00395967
165210165210Amount of Lactose Causing Symptoms in Lactose Intolerant PeopleCompletedNo Results AvailableLactose Intolerancehttps://ClinicalTrials.gov/show/NCT00395954

* Görseller ve İçerik tekif hakkına sahip olabilir